Kailera Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KLRA and other ETFs, options, and stocks.About KLRA
Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide.
KLRA Key Statistics
Stock Snapshot
With a market cap of 2.85B, Kailera Therapeutics(KLRA) trades at $22.03.
As of 2026-07-01, Kailera Therapeutics(KLRA) stock has fluctuated between $20.89 and $22.21. The current price stands at $22.03, placing the stock +5.5% above today's low and -0.8% off the high.
The Kailera Therapeutics(KLRA)'s current trading volume is 837.91K, compared to an average daily volume of 1.69M.
During the past year, Kailera Therapeutics(KLRA) stock moved between $16.00 at its lowest and $28.23 at its peak.
During the past year, Kailera Therapeutics(KLRA) stock moved between $16.00 at its lowest and $28.23 at its peak.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.